Browse Articles

To understand the true otherness of Neanderthals, researchers must rethink the meaning they give to their archaeological finds, argues a new book.

Some researchers publish a new paper every five days, on average. Data trackers suspect not all their manuscripts were produced through honest labour.

Researchers get an unprecedented glimpse of how ions behave during a drive.

Genetically modified blood cells could churn out therapeutic proteins for treating inflammation and other conditions.

From rugby refereeing to film and television work, a poll reveals scientists’ first jobs and what they learnt from them.

Murder most horrid.

Billion-euro plan includes greater oversight for national research institutes and the creation of a top-level council to advise the president on science.

Researchers who are as skilled in the studio as they are in the lab are forced to chooose between disciplines.

The first global declaration on reducing the eye-watering emissions from food production is a start, say researchers – but sidesteps some of the most contentious issues.

Triaging undead research projects and learning to move on.

A candidate for the largest known protein might help killer aquatic bacteria to devour other microbes — but it’s not easy to study the behemoths, or prove they’re even real.

Particulate-matter levels in US homes peak during mealtime — and especially on Thanksgiving and Christmas.

Scientists studying the electrical charge on coffee particles stumble on a secret to a better cup of joe.

Your major organs can age at different rates — and organs that look old before their time are linked to disease risk. Plus, sisal menstrual pads show the power of ‘frugal innovation’ and the first self-amplifying RNA vaccine wins full regulatory approval.

From drivable bionic animals to machines made from muscle, biohybrid robots are on their way to a variety of uses.

The new bargaining group will represent thousands of early-career scientists at the US National Institutes of Health.

Platforms based on molecules manipulated using ‘optical tweezers’ might be able to perform complex physics calculations.

Landmark approval of the first CRISPR therapy paves the way for treatments based on more efficient and more precise genome editors.

Report also supports projects of unprecedented scale to study dark matter, neutrinos and the Higgs boson.